AFX Endovascular AAA System BA22-60/I16-40Recalls & reported problems
Endologix LLC · Class 3 · Implant
All models of AFX Endovascular AAA System (48)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 4
- Deaths reported
- 0
- Injuries reported
- 4
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 4 adverse event reports that list this exact device (DI 00818009010193), received between Aug 12, 2016 and Aug 30, 2021 — classified as 4 injuries.
The most frequently reported specific device problem is “Insufficient Device Problem Information” (2 reports).
16 other recalls cover devices cleared under the same FDA submission (P040002); they may or may not involve this specific model.
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Most reported problems
Device problems
- Insufficient Device Problem Information2
- Adverse Event Without Identified Device or Use Problem1
- Difficult or Delayed Positioning1
- Difficult to Remove1
Patient problems
- Failure of Implant3
- Aortic Dissection1
- Cardiopulmonary Arrest1
- Death1
- Hematoma1
- Rupture1
Recent adverse event reports
The 4 most recent of 4 reports, in the reporter's own words as published by the FDA.
InjuryAug 30, 2021Insufficient Device Problem Information; Insufficient Device Problem Information
PROCEDURE PLANNING: (B)(6) 2020, (B)(6) 2021 CT SCAN: (B)(6) 2021
Patient problems: Failure of Implant
MAUDE report 12388277 ↗InjuryJan 25, 2021Insufficient Device Problem Information; Insufficient Device Problem Information
THE PATIENT WAS INITIALLY IMPLANTED WITH A AFX2 BIFURCATED STENT GRAFT, A VELA SUPRARENAL AND A VELA INFARENAL ENDOGRAFT TO TREAT A ABDOMINAL AORTIC ANEURYSM (AAA). APPROXIMATELY (4) FOUR YEARS POST INITIAL PROCEDURE, A TYPE 3A ENDOLEAK WITH DEVICE SEPARATION CAUSING A RUPTURE AAA WAS IDENTIFIED. THE PATIENT WAS BEING TRANSFERRED TO A DIFFERENT HOSPITAL FOR TREATMENT HOWEVER WENT INTO CARDIAC ARREST. PER PATIENT¿S FAMILY REQUEST NO ADDITIONAL TREATMENT WAS PERFORMED AND THE PATIENT EXPIRED ON (B)(6) 2020.
Patient problems: Cardiopulmonary Arrest; Death; Failure of Implant; Rupture
MAUDE report 11228196 ↗InjuryOct 17, 2017Difficult to Remove; Difficult to Remove
AN AFX ABDOMINAL STENT GRAFT SYSTEM WAS IMPLANTED TO TREAT AN ABDOMINAL AORTIC ANEURYSM. UPON RETRACTION OF THE CONTRALATERAL WIRE OF THE AFX SYSTEM, THE PHYSICIAN WAS MET WITH RESISTANCE. THE LIMB CAP WAS OBSERVED TO BE HITTING THE SHEATH, SO A SHEATH DILATOR WAS INSERTED OVER THE WIRE, AND THE PHYSICIAN ATTEMPTED TO PULL BACK AND REMOVE THE LIMB CAP. THIS LEAD TO THE CONTRALATERAL SHEATH BEING CRUSHED. A HEMATOMA FORMED ON THE ACCESS SITE DUE TO THIS. AS OF THE DATE OF THIS REPORT, THERE HAVE BEEN NO ADDITIONAL PATIENT SEQUELAE REPORTED.
Patient problems: Failure of Implant; Hematoma
MAUDE report 6955516 ↗InjuryAug 12, 2016Difficult or Delayed Positioning; Adverse Event Without Identified Device or Use Problem; Difficult or Delayed Positioning; Adverse Event Without Identified Device or Use Problem
IT WAS REPORTED THAT DURING THE INITIAL PROCEDURE ON (B)(6) 2016, PHYSICIAN NOTED THE ANEURYSMAL RIGHT COMMON ILIAC ARTERY HAD MODERATE CALCIFICATION AND MODERATE TORTUOSITY AND THE LEFT EXTERNAL ILIAC ARTERY WAS NARROW WITH CALCIFICATION. DURING DEPLOYMENT OF THE BIFURCATED DEVICE, IT WAS DIFFICULT TO DEPLOY THE CONTRALATERAL SIDE DUE TO PATIENT ANATOMY. AFTER DEPLOYMENT, PROCEDURE WAS COMPLETED, BUT PHYSICIAN NOTED THAT THE LEG WAS PULSELESS AND THAT BLOOD CIRCULATION WAS NOT MADE AT THE PERIPHERY. THIS WAS DUE TO A DISSECTION IN THE LEFT EXTERNAL ILIAC ARTERY THAT WAS RESOLVED BY IMPLANTING A NON-ENDOLOGIX STENT. PHYSICIAN ELECTED TO ALSO IMPLANT A LIMB EXTENSION TO BETTER SEAL THE LEFT COMMON ILIAC ARTERY, WHICH WAS ALSO DIFFICULT TO DEPLOY DUE TO DEVICE BEING CAUGHT BY AN EDGE OF THE CONTRALATERAL LIMB OF THE BIFURCATED DEVICE. PHYSICIAN WAS ABLE TO DEPLOY THE LIMB EXTENSION AND COMPLETE THE PROCEDURE. PATIENT IS IN STABLE CONDITION.
Patient problems: Aortic Dissection
MAUDE report 5871945 ↗
Recalls under the same FDA submission
These recalls involve devices cleared under P040002. One submission often covers many models, so check the product and lot details in each record.
- Z-1048-2017 · Jan 4, 2017 · TerminatedAFX Endovascular AAA System Item Number Item Description F0070305 A2525/C75 V F0070308 A2828/C75 V F0070312 A3434/C
- Z-1049-2017 · Jan 4, 2017 · TerminatedAFX2 Endovascular AAA System Item No. Item Description F00820-01 BEA28-120/I20-40 F00820-02 BEA28-100/I20-40 F00820-03 BEA28-80/I20-40 F00820-06 BEA28-120/I16-40 F00820-07 B
- Z-1039-2017 · Dec 27, 2016 · TerminatedAFX Endovascular AAA System, Endoleak Type: IIIB Common Name: AFX Bifurcated and Accessory Stent Grafts Classification Name: System, Endovascular Graft, Aortic Aneurysm Treatment
- Z-1054-2017 · Dec 27, 2016 · TerminatedAFX Endovascular AAA System, Endoleak Type IIIB Common Name: AFX Bifurcated and Accessory Stent Grafts Classification Name: System, Endovascular Graft, Aortic Aneurysm Treatment
- Z-1038-2017 · Dec 27, 2016 · TerminatedAFX Endovascular AAA System, Endoleak Type IIIB; The AFX Endovascular AAA System is intended for endovascular treatment of patients with abdominal aortic or aortoiliac aneurysms (A
- Z-1047-2017 · Dec 27, 2016 · TerminatedAFX Endovascular AAA System, Endoleak Type IIIA Product Usage: The AFX Endovascular AAA System is intended for endovascular treatment of patients with abdominal aortic or aortoili
- Z-1037-2017 · Dec 27, 2016 · TerminatedAFX Endovascular AAA System, Endoleak Type IIIA Common Name: AFX Bifurcated and Accessory Stent Grafts Classification Name: System, Endovascular Graft, Aortic Aneurysm Treatment
- Z-1035-2017 · Dec 27, 2016 · TerminatedAFX Endovascular AAA System, Endoleak Type IIIA
- Z-0595-06 · Dec 14, 2005 · TerminatedPowerlink System for Abdominal Aortic Aneurysm (Endoluminal Bifurcated Prosthesis with Delivery System) Model No. 28-16-140BL
- Z-0589-06 · Dec 14, 2005 · TerminatedPowerlink System for Abdominal Aortic Aneurysm (Endoluminal Bifurcated Prosthesis with Delivery System) Model No. 25-16-140BL
- Z-0593-06 · Dec 14, 2005 · TerminatedPowerlink System for Abdominal Aortic Aneurysm (Endoluminal Bifurcated Prosthesis with Delivery System) Model No. 25-16-155BL
- Z-0596-06 · Dec 14, 2005 · TerminatedPowerlink System for Abdominal Aortic Aneurysm (Endoluminal Bifurcated Prosthesis with Delivery System) Model No. 28-16-155BL
- Z-0590-06 · Dec 14, 2005 · TerminatedPowerlink System for Abdominal Aortic Aneurysm (Endoluminal Bifurcated Prosthesis with Delivery System) Model No. 25-16-155BL
- Z-0594-06 · Dec 14, 2005 · TerminatedPowerlink System for Abdominal Aortic Aneurysm (Endoluminal Bifurcated Prosthesis with Delivery System) Model No. 28-16-135BL
- Z-0591-06 · Dec 14, 2005 · TerminatedPowerlink System for Abdominal Aortic Aneurysm (Endoluminal Bifurcated Prosthesis with Delivery System) Model No. 25-16-135BL
…and 1 more.
Other System, Endovascular Graft, Aortic Aneurysm Treatment devices
- Endurant® IIs ESBF2814C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls34 deaths254 reports
- Endurant® IIs ESBF3214C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls19 deaths173 reports
- Endurant® IIs ESBF3614C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT1 recall37 deaths214 reports
- Endurant® IIs ESBF2514C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls18 deaths136 reports
- Endurant® IIs ESBF2314C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls9 deaths60 reports
- RelayPro Thoracic Stent-Graft System 28-N4-34-154-34UBolton Medical Inc. · System, Endovascular Graft, Aortic Aneurysm Treatment3 recalls7 reports
- Vela Proximal Endograft System A34-34/C100-O20 VEndologix LLC · System, Endovascular Graft, Aortic Aneurysm Treatment3 deaths152 reports
- Endurant® II ETCF2828C49EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls7 deaths44 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page